Nuo Therapeutics, Inc. financial data

Symbol
AURX on OTC
Location
8285 El Rio, Suite 150, Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % -42.5%
Quick Ratio 16.3 % -45.8%
Debt-to-equity 1.38K % +979%
Return On Equity -2.7K % -575%
Return On Assets -183 % -4.06%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.8M shares +3%
Common Stock, Shares, Outstanding 46.8M shares +2.99%
Entity Public Float 10M USD -72.1%
Common Stock, Value, Issued 4.68K USD +2.99%
Weighted Average Number of Shares Outstanding, Basic 46.8M shares +4.85%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -2.6M USD +3.31%
Nonoperating Income (Expense) 2.33K USD +23.4%
Net Income (Loss) Attributable to Parent -2.47M USD +8.25%
Earnings Per Share, Basic 0 USD/shares +28.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 316K USD -33.1%
Accounts Receivable, after Allowance for Credit Loss, Current 320K USD +5.07%
Inventory, Net 166K USD -23.5%
Assets, Current 853K USD -27.4%
Property, Plant and Equipment, Net 370K USD +789%
Operating Lease, Right-of-Use Asset 136K USD -33.4%
Assets 1.36M USD -4.29%
Accounts Payable, Current 313K USD -21.3%
Accrued Liabilities, Current 315K USD +36.6%
Liabilities, Current 999K USD +44.7%
Operating Lease, Liability, Noncurrent 60.1K USD -54.3%
Liabilities 2.18M USD +166%
Retained Earnings (Accumulated Deficit) -33.7M USD -7.92%
Stockholders' Equity Attributable to Parent -825K USD -238%
Liabilities and Equity 1.36M USD -4.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.83K USD
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -230K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 46.8M shares +2.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -228K USD +59.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 300K USD -36.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.72K USD +41.5%
Deferred Tax Assets, Valuation Allowance 40.7M USD -1.25%
Deferred Tax Assets, Gross 40.7M USD -1.25%
Operating Lease, Liability 132K USD -32.2%
Depreciation 53.9K USD +260%
Payments to Acquire Property, Plant, and Equipment 230K USD
Lessee, Operating Lease, Liability, to be Paid 144K USD -35.4%
Property, Plant and Equipment, Gross 841K USD +83.3%
Operating Lease, Liability, Current 71.5K USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 82.7K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 40.1K USD -50%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.5K USD -57%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.3K USD +0.01%
Deferred Tax Assets, Operating Loss Carryforwards 40.5M USD -1.13%
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.3K USD -74.3%
Additional Paid in Capital 32.8M USD +3.3%
Share-based Payment Arrangement, Expense 93K USD +303%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%